Education
About Us
Working with TipRanks
Follow Us
Cara Therapeutics (CARA)
NASDAQ:CARA
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 23.03M | $ 135.08M | $ 19.89M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 21.47M | $ 28.01M | $ -93.28M |
| Operating Income | $ -18.66M | $ -21.19M | $ -89.08M | $ 5.38M | $ -111.68M |
| EBITDA | $ -17.25M | $ -20.45M | $ -88.19M | $ 5.59M | $ -111.48M |
| Net Income | $ -17.35M | $ -20.54M | $ -88.19M | $ 8.41M | $ -106.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.92M | $ 43.74M | $ 167.03M | $ 180.93M | $ 155.01M |
| Total Assets | $ 27.00M | $ 45.10M | $ 247.06M | $ 271.16M | $ 232.96M |
| Total Debt | $ 368.00K | $ 450.00K | $ 3.67M | $ 5.28M | $ 4.32M |
| Net Debt | $ -22.55M | $ -21.04M | $ -9.78M | $ -26.41M | $ -13.99M |
| Total Liabilities | $ 89.06M | $ 90.15M | $ 19.53M | $ 22.16M | $ 46.25M |
| Stockholders' Equity | $ -62.06M | $ -45.05M | $ 227.52M | $ 249.00M | $ 186.71M |
| Cash Flow | |||||
| Free Cash Flow | $ -21.04M | $ -17.92M | $ -60.13M | $ -5.84M | $ -109.24M |
| Operating Cash Flow | $ -21.04M | $ -17.87M | $ -60.09M | $ -5.49M | $ -109.22M |
| Investing Cash Flow | $ 22.47M | $ -22.00M | $ -4.75M | $ -20.27M | $ -30.52M |
| Financing Cash Flow | $ 2.00K | $ 4.00K | $ 46.61M | $ 39.14M | $ 142.60M |